Prostate Cancer News
Differences in metabolism between androgen-dependent and castration resistant prostate cancer may lead to new therapies May 19, 2016 Researchers have determined that castration resistant prostate cancer has particular metabolic characteristics that may open new possibilities for treatment.
Electronic trigger reduces delays in evaluation for cancer diagnosis Aug 24, 2015 Electronic triggers designed to search for key data were able to identify and reduce follow-up delays for patients being evaluated for a diagnosis of colon or prostate cancer.
Baylor’s Dan L Duncan Cancer Center receives highest National Cancer Institute designation – Comprehensive status Jul 30, 2015 The National Cancer Institute has awarded the Dan L Duncan Cancer Center at Baylor College of Medicine the prestigious designation of a Comprehensive Cancer Center.
Baylor College of Medicine's Duncan Cancer Center receives additional $15.9 million in state cancer funding May 29, 2015 Researchers in the NCI-designated Dan L Duncan Cancer Center at Baylor College of Medicine have received $15.9 million from the Cancer Prevention and Research Institute of Texas for two new large grants focused on liver cancer and prostate cancer.
Baylor College of Medicine receives an additional $11 million in state cancer funding Feb 23, 2015 Baylor researchers receive nine new grants totaling $11.3 million in the latest round of funding awarded by the Cancer Prevention and Research Institute of Texas.
Coactivator forges pathway for prostate cancer metastatic survival Feb 16, 2015 New finding could help define pathway to develop a drug against prostate cancer metastasis, according to researchers at Baylor.
Study looks at effect of diet on prostate cancer progression Jan 9, 2015 Recent studies suggest that nutrients found primarily in vegetables and fruits can help lower the risk of prostate cancer.
Facial hair brings awareness to unique medical approaches, treatments at Baylor College of Medicine Nov 14, 2014 The Movember and No-Shave November movements have men’s health in their crosshairs, and Baylor College of Medicine is doing its part to raise awareness by providing individualized, tailored approaches to prostate cancer screening and erectile dysfunction.
SRC-2 drives castration-resistant prostate cancer Oct 9, 2014 Finding a blocker for the nuclear receptor coactivator known as NCoA2 or SRC-2 might solve the problem of treating advanced prostate cancer that becomes resistant to the most common treatment.
High throughput “viewing” identifies new regulator of estrogen receptor Jan 23, 2014 A high throughput microscopy technique enabled our researchers to identify a a highly amplified gene in many tumors, including breast, prostate and ovarian cancer.